Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

The medical director of stroke at Fairview Hospital, an affiliate of Cleveland Clinic, provided perspective on a new intervention that improves communication and reduces hospital readmission for stroke.

NeuroVoices: Shumei Man, MD, on How Collaboration Between Hospitals Reduces Readmission for Stroke

During a 12-week treatment period, investigators observed greater reduction in change from baseline in UPDRS score for those on electroacupuncture than just on PD medication alone.

Electroacupuncture Provides Additive Benefits for Motor Function and Bowel Movements in Parkinson Disease

Videos

The assistant professor of neurology at Yale School of Medicine spoke about the importance of the relaunch of the patient registry for research in myasthenia gravis. [WATCH TIME: 3 minutes]  

Significance of Relaunched Patient Registry for Myasthenia Gravis Research: Richard Nowark, MD, MS

The trial was originally placed on hold because of reported cases of drug-induced liver injury in patients who received the study drug, potentially caused by a preexisting factors related to hepatic dysfunction.

Sanofi Discontinues Phase 3 Study of Tolebrutinib in Myasthenia Gravis

, has been with the team since October 2019. Follow him on Twitter 

The chief training and education officer at the Parkinson’s Foundation detailed the challenges in disseminating educational materials to the clinical community that could have impacts on Parkinson disease care. [WATCH TIME: 5 minutes]

Reaching a Broader Community of Health Care Professionals to Improve PD Care: Eli Pollard

The chief training and education officer at the Parkinson’s Foundation discussed the importance of educating healthcare professionals on different specialists that play a role in Parkinson disease management. [WATCH TIME: 2 minutes]

Educating and Diversifying Clinicians to Help Overcome Gaps in Parkinson Disease Management: Eli Pollard

The director of the Montefiore Einstein Center for the Aging Brain provided insight on expanding the use of the 5-Cog tool, and whether it can be used for other conditions like HIV or COVID-19. [WATCH TIME: 3 minutes]

Adopting the 5-Cog Assessment Nationally, Other Cognitive Conditions: Joe Verghese, MBBS, MS

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Slideshows

PPP is a disabling and chronic condition marked by symptoms, such as anxiety, muscle weakness, pain, fatigue, and temporary paralysis.

Rare Diseases

Clinical

Primary Periodic Paralysis 101

Primary Periodic Paralysis 101

5 Pending FDA Decisions in Neurology to Look for in 2023

Phase 2 Trial for Angelman Syndrome Underway

Out-of-Pocket Costs Steadily Increasing for Neurologic Care

Curious Results in Myasthenia Gravis Study

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

GW Submits sNDA for CBD in Tuberous Sclerosis Complex

5 Pending FDA Decisions in Neurology to Look for in 2023

Phase 2 Trial for Angelman Syndrome Underway

Out-of-Pocket Costs Steadily Increasing for Neurologic Care

Curious Results in Myasthenia Gravis Study

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

GW Submits sNDA for CBD in Tuberous Sclerosis Complex

5 Pending FDA Decisions in Neurology to Look for in 2023

Phase 2 Trial for Angelman Syndrome Underway

Out-of-Pocket Costs Steadily Increasing for Neurologic Care

Curious Results in Myasthenia Gravis Study

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

GW Submits sNDA for CBD in Tuberous Sclerosis Complex